Navigation Links
Ben-Gurion U. establishes stem cell research fund in honor of inventor Jordan Baruch
Date:1/15/2013

CHEVY CHASE, MD, January 15, 2013 -- American Associates, Ben-Gurion University of the Negev (AABGU) received a substantial donation from Rhoda Baruch, wife of the late Dr. Jordan Baruch, to fund stem cell research at Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel.

The Jordan Baruch Stem Cell Research Fund was dedicated at the University on December 30 in the presence of Rhoda Baruch and 20 members of her extended family.

"Jordan recognized that here at Ben-Gurion University are the people who walk the extra mile and who are dedicated to the less fortunate. What the people of BGU have in addition to their brilliance and creativity is a sense of compassion and dedication that touched us so much. If anyone can do it, you guys can do it," Baruch declared.

The donation will support scholarly collaboration between specially selected medical and pharmacological researchers, stem cell biologists and tissue engineers. It will support the work of BGU's new Center for Regenerative Medicine, Cellular Therapy and Stem Cell Research.

"Jordan was a passionate supporter of Israel and especially BGU," says Keren Waranch, director of the Washington-Baltimore Region of American Associates, Ben-Gurion University of the Negev (AABGU), who also attended the dedication.

"He and Rhoda founded the local AABGU chapter in the 1980s and funded the Mendel Wasserman Career Development Chair in Desert Studies, named in memory of Rhoda's father.

"We are extremely grateful to Rhoda for this generous contribution and moving tribute to her husband of 67 years," Waranch adds. "This fund will launch BGU forward in researching the treatment and potential cure for debilitating diseases such as diabetes, ALS, Parkinson's and leukemia."

Dr. Baruch (pronounced Bah-ROOSH), who died in 2011, was considered one of the foremost authorities in the field of acoustics. He held several patents for sound-dampening technology an
'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
3. Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
4. Preeclampsia poses a significant long-term health risk according to new research from Ben-Gurion U.
5. Ben-Gurion University team in prestigious DARPA Robotics Challenge to develop disaster response robot
6. New genetic bar code technique establishes ability to derive DNA information from RNA
7. DFG establishes 10 new priority programs
8. Notre Dame establishes professorships in adult stem cell research
9. JoVE establishes Librarian Advisory Board
10. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
11. Research reveals first evidence of hunting by prehistoric Ohioans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... sugar alcohol produced by fungi, bacteria, and algae, is ... sweetener is also used in the medical field ... flush out excess fluids and used during surgery as ... the passage of other drugs. , Now Profs. Ehud ... of Molecular Microbiology and Biotechnology and the Sagol School ...
(Date:6/17/2013)... shale gas, is widespread across Pennsylvania, covering up to ... the Annals of the New York Academy of ... pollution from toxic chemicals, the building of well pads ... has engendered a great deal of controversy, largely because ... biological diversity and resources have scarcely been addressed in ...
(Date:6/16/2013)... a similar marine ecosystem crisis to those witnessed in ... to research published today in Nature Geoscience ., ... Newcastle, UK, Cologne, Frankfurt and GEOMAR-Kiel, confirms the link ... ecosystem during the mid-Cretaceous greenhouse period. It ... duration of the temperature change.,Analysing the geochemistry and micropaleontology ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Global cooling as significant as global warming 2
... (fMRI) is a powerful noninvasive tool for studying brain ... studies are carried out on adults, but this technique ... That potential is hampered, however, by a lack of ... the developing brain. Now, by studying rats, MIT neuroscientists ...
... Technology recently received a research grant from the ... Functional Polymers Modified Surfaces with Biofilm Sensitizing Ability. ... Department of Chemistry and Chemical Biology, will serve ... is an assemblage of microbial cells that is ...
... called for the guidance documents for the implementation of ... The consensus among the scientists and stakeholders who discussed ... Environmental Research (UFZ) in November was that the Directive ... taken further. The experts can already see that the ...
Cached Biology News:Using fMRI to study brain development 2Further development of Water Framework Directive necessary 2Further development of Water Framework Directive necessary 3
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 ... services MeMD, Inc proudly announces the release of ... Health and Fitness ". , MeMD's goal was ... ever-changing landscape of Health 2.0, Health 3.0 and ... will likely transform medical care and the fitness ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 Though ... -- 11,000, according to the U.S. Bureau of Labor Statistics ... increase of 24,000 per month. Most new health care jobs ... the hospital sector saw a loss of 6,000 jobs. Overall, ... outplacement consultancy firm Challenger, Gray & Christmas reported that a ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2
... a dorm refrigerator in one of Himadri B. Pakrasi,s labs, a ... of red, blue and green LEDS. This isn,t just any ... is colored by a strain of blue-green bacteria that bubble off ... part because of their unique genetic endowment but also in part ...
... 14, 2010 BIOSAFE, Inc. has announced that ... water-based antimicrobial solutions and entered into a commercialization ... products containing BIOSAFE,s patented and exclusive antimicrobial polymer, ... protects surfaces from harmful and degrading effects of ...
... 2010 Tolerx, Inc., a biopharmaceutical company developing novel ... T cell activity, today announced that it has initiated ... tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal ... T cells to more effectively attack cancer cells.   ...
Cached Biology Technology:Champion hydrogen-producing microbe 2Champion hydrogen-producing microbe 3Champion hydrogen-producing microbe 4Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals 2Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals 3Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 3
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: